These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24498420)

  • 1. JMJD6 regulates ERα methylation on arginine.
    Poulard C; Rambaud J; Hussein N; Corbo L; Le Romancer M
    PLoS One; 2014; 9(2):e87982. PubMed ID: 24498420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JMJD6 Licenses ERα-Dependent Enhancer and Coding Gene Activation by Modulating the Recruitment of the CARM1/MED12 Co-activator Complex.
    Gao WW; Xiao RQ; Zhang WJ; Hu YR; Peng BL; Li WJ; He YH; Shen HF; Ding JC; Huang QX; Ye TY; Li Y; Liu ZY; Ding R; Rosenfeld MG; Liu W
    Mol Cell; 2018 Apr; 70(2):340-357.e8. PubMed ID: 29628309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone arginine demethylase JMJD6 is linked to stress granule assembly through demethylation of the stress granule-nucleating protein G3BP1.
    Tsai WC; Reineke LC; Jain A; Jung SY; Lloyd RE
    J Biol Chem; 2017 Nov; 292(46):18886-18896. PubMed ID: 28972166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein arginine methylation/demethylation and cancer.
    Poulard C; Corbo L; Le Romancer M
    Oncotarget; 2016 Oct; 7(41):67532-67550. PubMed ID: 27556302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JMJD6 is a histone arginine demethylase.
    Chang B; Chen Y; Zhao Y; Bruick RK
    Science; 2007 Oct; 318(5849):444-7. PubMed ID: 17947579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hydroxylation activity of Jmjd6 is required for its homo-oligomerization.
    Han G; Li J; Wang Y; Li X; Mao H; Liu Y; Chen CD
    J Cell Biochem; 2012 May; 113(5):1663-70. PubMed ID: 22189873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JMJD6 induces HOTAIR, an oncogenic lincRNA, by physically interacting with its proximal promoter.
    Biswas A; Shettar A; Mukherjee G; Kondaiah P; Desai KV
    Biochem J; 2018 Jan; 475(1):355-371. PubMed ID: 29229759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic Arginine Methylation of Tumor Necrosis Factor (TNF) Receptor-associated Factor 6 Regulates Toll-like Receptor Signaling.
    Tikhanovich I; Kuravi S; Artigues A; Villar MT; Dorko K; Nawabi A; Roberts B; Weinman SA
    J Biol Chem; 2015 Sep; 290(36):22236-49. PubMed ID: 26221041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redistribution of demethylated RNA helicase A during foot-and-mouth disease virus infection: role of Jumonji C-domain containing protein 6 in RHA demethylation.
    Lawrence P; Conderino JS; Rieder E
    Virology; 2014 Mar; 452-453():1-11. PubMed ID: 24606677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JMJD6 orchestrates a transcriptional program in favor of endocrine resistance in ER+ breast cancer cells.
    Das P; Gupta A; Desai KV
    Front Endocrinol (Lausanne); 2022; 13():1028616. PubMed ID: 36419768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and structural investigations clarify the substrate selectivity of the 2-oxoglutarate oxygenase JMJD6.
    Islam MS; McDonough MA; Chowdhury R; Gault J; Khan A; Pires E; Schofield CJ
    J Biol Chem; 2019 Jul; 294(30):11637-11652. PubMed ID: 31147442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of JMJD6 in Breast Tumourigenesis.
    Poulard C; Rambaud J; Lavergne E; Jacquemetton J; Renoir JM; Trédan O; Chabaud S; Treilleux I; Corbo L; Le Romancer M
    PLoS One; 2015; 10(5):e0126181. PubMed ID: 25951181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-491-5p functions as a tumor suppressor by targeting JMJD2B in ERα-positive breast cancer.
    Hui Z; Yiling C; Wenting Y; XuQun H; ChuanYi Z; Hui L
    FEBS Lett; 2015 Mar; 589(7):812-21. PubMed ID: 25725194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis.
    Shi L; Sun L; Li Q; Liang J; Yu W; Yi X; Yang X; Li Y; Han X; Zhang Y; Xuan C; Yao Z; Shang Y
    Proc Natl Acad Sci U S A; 2011 May; 108(18):7541-6. PubMed ID: 21502505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Jmjd6 cellular localization and testing for its involvement in histone demethylation.
    Hahn P; Wegener I; Burrells A; Böse J; Wolf A; Erck C; Butler D; Schofield CJ; Böttger A; Lengeling A
    PLoS One; 2010 Oct; 5(10):e13769. PubMed ID: 21060799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic features of the JMJD2A histone demethylase in breast cancer.
    Berry WL; Shin S; Lightfoot SA; Janknecht R
    Int J Oncol; 2012 Nov; 41(5):1701-6. PubMed ID: 22948256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer.
    Lee YF; Miller LD; Chan XB; Black MA; Pang B; Ong CW; Salto-Tellez M; Liu ET; Desai KV
    Breast Cancer Res; 2012 May; 14(3):R85. PubMed ID: 22621393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PELP1 oncogenic functions involve CARM1 regulation.
    Mann M; Cortez V; Vadlamudi R
    Carcinogenesis; 2013 Jul; 34(7):1468-75. PubMed ID: 23486015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of JMJD6 by 2-Oxoglutarate Mimics.
    Islam MS; Thinnes CC; Holt-Martyn JP; Chowdhury R; McDonough MA; Schofield CJ
    ChemMedChem; 2022 Jan; 17(1):e202100398. PubMed ID: 34581506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.